Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
NCT06031246

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Led by Fudan University · Updated on 2023-09-11

634

Participants Needed

1

Research Sites

404 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1018. The goal of this clinical trial is to confirm the theraputic effect of selective lymph node dissection for cT1N0M0 invasive non-small cell lung cancer with CTR\>0.5 located in the apical segment. The main questions it aims to answer are: The 5-year overall survival of patients having cT1N0M0 invasive non-small cell lung cancer with CTR\>0.5 located in the apical segment; The post-operative lymph node metastasis and recurrence-free survival. Participants will receive selective lymph node dissection as the surgical procedure.

CONDITIONS

Official Title

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent and willingness to complete the study
  • Aged 18 to 80 years
  • ECOG performance status of 0 or 1
  • No previous lung cancer surgery
  • Resectable peripheral cT1N0M0 tumors with CTR > 0.5 located in the apical segment
  • Non-lepidic predominant invasive NSCLC diagnosed by frozen section
  • No prior chemotherapy or radiotherapy
Not Eligible

You will not qualify if you...

  • Not having cT1N0M0 stage
  • Nodules not located in the apical segment or with CTR ≤ 0.5
  • Pre-invasive lung adenocarcinoma, lepidic predominant adenocarcinoma, or non-lung adenocarcinoma diagnosed cytologically or pathologically
  • Previous lung cancer surgery
  • Prior radiotherapy or chemotherapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chaoqiang Deng

Shanghai, Please Select, China, 200032

Actively Recruiting

Loading map...

Research Team

C

Chaoqiang Deng, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here